| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/23/1999 | EP0923736A1 Use of a carrier material for sample preparation and detection for a genetic-engineering analysis process |
| 06/23/1999 | EP0923650A1 Sequencing by ligation of encoded adaptors |
| 06/23/1999 | EP0923648A1 Gene conferring disease resistance in plants and uses thereof |
| 06/23/1999 | EP0923647A1 Method for mass production of antimicrobial peptide |
| 06/23/1999 | EP0923646A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 06/23/1999 | EP0923645A1 Insect neuropeptides genes and peptides |
| 06/23/1999 | EP0923644A1 G-coupled receptor showing selective affinity for atp |
| 06/23/1999 | EP0923643A1 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 06/23/1999 | EP0923642A1 Active survival domains of igf-ir and methods of use |
| 06/23/1999 | EP0923608A1 Endoglucanases |
| 06/23/1999 | EP0923606A1 ANTIGENIC FUSIONPROTEIN CARRYING GAL$g(a)1,3GAL EPITOPES |
| 06/23/1999 | EP0923604A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects |
| 06/23/1999 | EP0923602A1 Immunocontraceptive compositions containing sperm antigens, and methods of use |
| 06/23/1999 | EP0923600A2 Novel cationic amphiphilic lipids for liposomal gene transfer |
| 06/23/1999 | EP0923598A1 Production and use of normalized dna libraries |
| 06/23/1999 | EP0923597A1 Substituted propargylethoxyamido nucleosides |
| 06/23/1999 | EP0923592A1 Methods for purifying nucleic acids |
| 06/23/1999 | EP0923591A1 Novel boronic acid-containing nucleic acids and their use as diagnostic agents |
| 06/23/1999 | EP0923388A1 Use of microorganisms for processing bioprosthetic tissue |
| 06/23/1999 | EP0923308A1 Purification of biologically active peptides from milk |
| 06/23/1999 | EP0923306A1 Frozen food with antifreeze peptides |
| 06/23/1999 | EP0923304A1 Soybean oil having high oxidative stability |
| 06/23/1999 | EP0923295A1 Pesticidal agents |
| 06/23/1999 | EP0923284A1 Cellular immunogens useful as cancer vaccines |
| 06/23/1999 | EP0814900A4 Pressure cycling reactor |
| 06/23/1999 | EP0722494A4 Transgenic plants that exhibit enhanced nitrogen assimilation |
| 06/23/1999 | EP0693078B1 Dna polymerases with enhanced thermostability and enhanced length and efficiency of primer extension |
| 06/23/1999 | EP0690876B1 Protein kinases |
| 06/23/1999 | EP0628639B1 Reconstituted human antibody against human interleukin 6 receptor |
| 06/23/1999 | EP0605522B1 Methods for the production of humanized antibodies |
| 06/23/1999 | EP0598816B1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 06/23/1999 | EP0559725B1 Structural proteins from artificial genes |
| 06/23/1999 | EP0496818B1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR |
| 06/23/1999 | CN1220701A Lipid kinase |
| 06/23/1999 | CN1220700A Antifungal polypeptide and methods for controlling plant pathogenic fungi |
| 06/23/1999 | CN1220699A Antibodies against interferon alpha/beta receptor |
| 06/23/1999 | CN1220698A C4 cycle of pck type |
| 06/23/1999 | CN1220697A Novel phytase and gene encoding said phytase |
| 06/23/1999 | CN1220608A Mammalian tolloid-like gene and protein |
| 06/23/1999 | CN1220314A Cytochrome C and its gene |
| 06/23/1999 | CA2256052A1 Genes of purine biosynthesis from ashbya gossypii and the use thereof in microbial riboflavin synthesis |
| 06/23/1999 | CA2255140A1 Echinocandin binding domain of 1,3-.beta.-glucan synthase |
| 06/22/1999 | US5914451 Efficiency soybean transformation protocol |
| 06/22/1999 | US5914450 Glutenin genes and their uses |
| 06/22/1999 | US5914449 Method for increasing storage lipid content in plant seed |
| 06/22/1999 | US5914448 Process for the preparation of antiviral plant transformed with lactoferrin gene |
| 06/22/1999 | US5914447 Transgenic plants including a transgene consisting of a hybrid nucleic acid sequence, comprising at least one unedited mitochondrial gene fragment from higher plants and process for producing them |
| 06/22/1999 | US5914446 Sweetness |
| 06/22/1999 | US5914395 Desmin enhancer sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells |
| 06/22/1999 | US5914390 Methods for increasing yields of recombinant proteins |
| 06/22/1999 | US5914318 Transgenic plants expressing lepidopteran-active δ-endotoxins |
| 06/22/1999 | US5914317 A dna which hybridizes under high stringency conditions to a preferential dna sequence encodes b1k proteins which contains atleast thirty amino acid residues in length; useful for treating dermis disorder such as epidermal bulosis |
| 06/22/1999 | US5914315 Isolated amino acid sequences encoding a kunitz-type inhibitor; anticoagulants for treating deep vein thrombosis |
| 06/22/1999 | US5914306 Containing nucleotide sequence having proline substituted at specified position(s) |
| 06/22/1999 | US5914270 Method for promoting the differentiation of plant cells in culture |
| 06/22/1999 | US5914269 With phosphorothioate intersugar linkages; for hybridization to messenger rna to prevent translation; antisense/anticarcinogenic/antitumor agents for lung, prostate, colon, and ovarian cancer |
| 06/22/1999 | US5914267 Chimeric rna which has an enhancer; capable of transcribing an intron dependent gene |
| 06/22/1999 | US5914265 Keratin K1 expression vectors and methods of use |
| 06/22/1999 | US5914261 Nucleic acid which codes for extracellular signal regulated kinase 1; for screening drugs for alzheimer's disease and other nervous system disorders; antidiabetic agents |
| 06/22/1999 | US5914260 Fish pancreatic disease virus |
| 06/22/1999 | US5914257 For efficient industrial oxidation of ethanol to acetic acid; qualitative analysis of aldehydes and oxidative decomposition of aldehydes which creat food odors |
| 06/22/1999 | US5914256 Method for promoting enzyme diversity |
| 06/22/1999 | US5914253 Dna coding for protein from mouse liver; anticarcinogenic/antitumor agents; platelet activator; antiseptic; viricides |
| 06/22/1999 | US5914252 Polype(tide found on the surface of synovial cells from patients with rheumatoid arthritis; for diagnostic reagents |
| 06/22/1999 | US5914251 Nucleic acid molecules encoding placental-derived growth factors |
| 06/22/1999 | US5914250 Gene which codes for mutant antibiotic having isoleucine substituted at 4 position of amino acid sequence |
| 06/22/1999 | US5914248 Method for controlling the gene expression in lactic acid bacteria |
| 06/22/1999 | US5914246 Multiple drug resistance gene of Aspergillus fumigatus |
| 06/22/1999 | US5914238 Materials and methods for detection of breast cancer |
| 06/22/1999 | US5914237 Kinase receptor activation assay |
| 06/22/1999 | US5914236 PCT-65 serotonin receptor |
| 06/22/1999 | US5914234 Methods of detecting growth differentiation factor-11 |
| 06/22/1999 | US5914231 Carrier of cationic, water soluble or water dispersable polymer; for gene therapy |
| 06/22/1999 | US5914230 Homogeneous amplification and detection of nucleic acids |
| 06/22/1999 | US5914123 Food comprising transgenic plant material, ingestible for nutritional value, expressing recombinant immunogen derived from hepatitis virus |
| 06/22/1999 | US5914111 Inhibiting t-cell activation by administering polypeptide having amino acids 1-92 of lymphocyte functioning associated antigen-3 joined to different protein or polypeptide comprising portion of immunoglobulin |
| 06/22/1999 | US5914106 Interleukin-6 receptor agonists |
| 06/22/1999 | CA2255284A1 Unicellular or multicellular organisms for preparing riboflavin |
| 06/22/1999 | CA1340605C Isolation and characterization of telomere sequences of a.thaliana |
| 06/22/1999 | CA1340600C Bacillus thuringiensis p-2 toxin gene |
| 06/22/1999 | CA1340599C Antibiotic-producing microorganisms |
| 06/22/1999 | CA1340597C Expression vectors containing pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, plasmids containing the vectors, hosts containing the plasmids and related methods |
| 06/20/1999 | CA2255143A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for searching for inhibitors and for the diagnosis or therapy of a disease |
| 06/20/1999 | CA2255141A1 Nucleic acid constructs for gene therapy whose activity is affected by inhibitors of cyclin-dependent kinases |
| 06/17/1999 | WO1999030164A1 Method to identify transcriptional modulators |
| 06/17/1999 | WO1999030157A2 Neuropilins in methods for diagnosis and prognosis of cancer |
| 06/17/1999 | WO1999030151A1 Method and cells to screen combinatorial libraries |
| 06/17/1999 | WO1999029907A1 Methods for making nucleic acids |
| 06/17/1999 | WO1999029906A2 Gene family with transformation modulating activity |
| 06/17/1999 | WO1999029905A2 Method for detecting apoptosis using fret labeled oligonucleotides |
| 06/17/1999 | WO1999029904A2 Methods and reagents for preservation of dna in bodily fluids |
| 06/17/1999 | WO1999029903A2 Cancer susceptibility mutations of brca1 |
| 06/17/1999 | WO1999029902A1 Method for creating polynucleotide and polypeptide sequences |
| 06/17/1999 | WO1999029898A2 Method for identifying nucleic acids by means of matrix-assisted laser desorption/ionisation mass spectrometry |
| 06/17/1999 | WO1999029897A1 Method for identifying nucleic acids by electro-spray mass spectrometry |
| 06/17/1999 | WO1999029896A1 Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof |
| 06/17/1999 | WO1999029890A2 Assessment of human papilloma virus-related disease |
| 06/17/1999 | WO1999029888A1 Humanization of murine antibody |
| 06/17/1999 | WO1999029887A1 Dna encoding a mammalian lpa receptor and uses thereof |
| 06/17/1999 | WO1999029884A2 Tgc method for inducting targeted somatic transgenesis |